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Proper regulation of gene expression is essential for cellu-
lar viability, and the integrity of chromatin is a fundamen-
tal factor in maintaining proper gene regulation. In cancer
cells, this precise regulation is disrupted and aberrant gene
expression ensues - a hallmark of the disease. In many
forms of hematological malignancy, aberrant expression,
activation or deletion of a critical enzymatic regulator of
chromatin modification underlies the disease. One such
regulator is MMSET (multiple myeloma SET domain)
protein, a histone methyltransferase, that is rearranged
and joined with the immunoglobulin locus associated with
t(4:14) due to aberrant class switch DNA recombination
in approximately 20% of multiple myeloma cases and is
associated with particularly poor prognosis. Our lab has
previously shown that an increase in MMSET expression
results in global histone modification changes and up-
regulation of hundreds of genes. We believe that these
changes are due to radical reprogramming of chromatin,
including repositioning of nucleosomes in MMSET-
overexpressed cells. Mechanistic insight into epigenetic
changes during MMSET-mediated gene expression will pro-
vide deeper understanding of disease progression in multi-
ple myeloma, and potentially other similar malignancies.
To begin understanding the changes in chromatin struc-
ture when MMSET is overexpressed, we generated a gen-
ome wide nucleosome map in cells expressing high and
low levels of MMSET. Initial analysis of this mapping
reveals changes in nucleosome positioning in promoters
where gene expression and histone modifications had been
identified to be significantly altered in cells expressing high
and low levels of MMSET. Generally, overexpression of
MMSET results in an increase in H3K36 dimethylation, a
histone modification associated with actively transcribed
genes, and a concomitant genome-wide loss of H3K27
trimethylation, a histone modification associated with
repressed genes. Indeed, in cells expressing high levels of
MMSET, genes that have been identified to have an
increase in expression and an increase in H3K36 dimethy-
lation have a distinct change in nucleosome positioning
compared to the cells expressing low levels of MMSET.
Further, differences in nucleosome positioning can be
detected in promoter regions with increased H3K27 tri-
methylation and decreased gene expression. We are cur-
rently examining whether these changes in nucleosome
positioning are due to the presence of MMSET and require
MMSET histone methyltransferase activity. Through these
and related studies, our aim is to determine how MMSET
behaves in multiple myeloma through a likely radical
reprogramming of chromatin. We believe that mechanistic
insight into MMSET-mediated gene expression changes
will provide significant avenues for potential therapeutic
strategies, as MMSET overexpression has been implicated
in myeloma and other solid tumors. Moreover, our work
will provide insight into mechanisms that may be shared
amongst various diseases that are initiated through epige-
netic misregulation.
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